Terms: = Skin cancer AND DDIT3, CHOP, 1649, ENSG00000175197, _C/EBP zeta_, MGC4154, GADD153, CHOP10, P35638
273 results:
1. PIKFYVE inhibitors trigger interleukin-24-dependent cell death of autophagy-dependent melanoma.
Roy A; Chakraborty AR; DePamphilis ML
Mol Oncol; 2024 Apr; 18(4):988-1011. PubMed ID: 38414326
[TBL] [Abstract] [Full Text] [Related]
2. SIRT7 sustains tumor development and radioresistance by repressing endoplasmic reticulum stress-induced apoptosis in cutaneous melanoma.
Meng B; Xu M; Chen Z; You J; Zhou R; Guan J; Zhou L
Cell Signal; 2024 Apr; 116():111058. PubMed ID: 38244711
[TBL] [Abstract] [Full Text] [Related]
3. Secondary malignancies among mantle cell lymphoma patients.
Abalo KD; Smedby KE; Ekberg S; Eloranta S; Pahnke S; Albertsson-Lindblad A; Jerkeman M; Glimelius I
Eur J Cancer; 2023 Dec; 195():113403. PubMed ID: 37952281
[TBL] [Abstract] [Full Text] [Related]
4. Case report: Successful treatment of Chidamide in a refractory/recurrent SPTCL with ARID1A mutation on the basis of chop plus auto-HSCT.
Zhang N; Zhang S; Ma L; Qiu L; Meng QL; Cai J; Xu Z; Yao H; Fan FY
Medicine (Baltimore); 2023 Oct; 102(40):e35413. PubMed ID: 37800816
[TBL] [Abstract] [Full Text] [Related]
5. Kuwanon H Inhibits Melanoma Growth through Cytotoxic Endoplasmic Reticulum Stress and Impaired Autophagy Flux.
Hu X; Pan G; Luo J; Gao X; Mu Y; Wang Z; Hu X; Li C; Abbas MN; Zhang K; Zheng Y; Cui H
J Agric Food Chem; 2023 Sep; 71(37):13768-13782. PubMed ID: 37672659
[TBL] [Abstract] [Full Text] [Related]
6. Shikonin Causes Non-apoptotic Cell Death in B16F10 Melanoma.
Ahmad H; Crotts MS; Jacobs JC; Baer RW; Cox JL
Anticancer Agents Med Chem; 2023; 23(16):1880-1887. PubMed ID: 37393553
[TBL] [Abstract] [Full Text] [Related]
7. BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting.
Sorbi C; Belluti S; Atene CG; Marocchi F; Linciano P; Roy N; Paradiso E; Casarini L; Ronsisvalle S; Zanocco-Marani T; Brasili L; Lanfrancone L; Imbriano C; Di Rocco G; Franchini S
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298633
[TBL] [Abstract] [Full Text] [Related]
8. Brentuximab-vedotin in combination with cyclophosphamide, doxorubicin, prednisolone for the treatment of aggressive CD30-positive cutaneous T-cell lymphomas.
Ribereau-Gayon E; Donzel M; Pham F; Romain-Scelle N; Perier-Muzet M; Balme B; Traverse-Glehen A; Ghesquières H; Dalle S
Leuk Lymphoma; 2023; 64(8):1424-1432. PubMed ID: 37255021
[TBL] [Abstract] [Full Text] [Related]
9. Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma Transforming into Diffuse Large B-Cell Lymphoma in a Young Adult Patient with Neurofibromatosis Type 1: A Case Report.
Kosako H; Yamashita Y; Tanaka K; Mishima H; Iwamoto R; Kinoshita A; Murata SI; Ohshima K; Yoshiura KI; Sonoki T; Tamura S
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557032
[No Abstract] [Full Text] [Related]
10. Clinical prognostic risk analysis and progression factor exploration of primary breast lymphoma.
Deng J; Mi L; Wang X; Zhu J; Zhang C; Song Y
Hematology; 2022 Dec; 27(1):1272-1281. PubMed ID: 36476227
[TBL] [Abstract] [Full Text] [Related]
11. Superficial GLI1-amplified mesenchymal neoplasms: Expanding the spectrum of an emerging entity which reaches the realm of dermatopathology.
Machado I; Hosler GA; Traves V; Claramunt R; Sanmartín O; Santonja C; Carvajal N; Zazo S; Requena L; Alfonso VS; Domenech EV; Llombart-Bosch A; Bridge JA; Linos K
J Cutan Pathol; 2023 Jun; 50(6):487-499. PubMed ID: 36316249
[TBL] [Abstract] [Full Text] [Related]
12. Clinical management of melanocytic tumours of uncertain malignant potential (MelTUMPs), including melanocytomas: A systematic review and meta-analysis.
Varey AHR; Williams GJ; Lo SN; Taing CY; Maurichi A; Santinami M; Scolyer RA; Thompson JF
J Eur Acad Dermatol Venereol; 2023 May; 37(5):859-870. PubMed ID: 36251355
[TBL] [Abstract] [Full Text] [Related]
13. NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling.
Verma S; Crawford D; Khateb A; Feng Y; Sergienko E; Pathria G; Ma CT; Olson SH; Scott D; Murad R; Ruppin E; Jackson M; Ronai ZA
Nat Cell Biol; 2022 Sep; 24(9):1422-1432. PubMed ID: 36050469
[TBL] [Abstract] [Full Text] [Related]
14. Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection.
Grześk E; Kołtan S; Dąbrowska A; Urbańczyk A; Małdyk J; Małkowski B; Bogiel T; Dębski R; Czyżewski K; Wysocki M; Styczyński J
Front Immunol; 2022; 13():915986. PubMed ID: 35990691
[TBL] [Abstract] [Full Text] [Related]
15. Synergistic antitumor effect of a penicillin derivative combined with thapsigargin in melanoma cells.
Bellizzi Y; Cornier PG; Delpiccolo CML; Mata EG; Blank V; Roguin LP
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3361-3373. PubMed ID: 35751681
[TBL] [Abstract] [Full Text] [Related]
16. Intravascular Large B-Cell Lymphoma: A Review with a Focus on the Prognostic Value of skin Involvement.
Breakell T; Waibel H; Schliep S; Ferstl B; Erdmann M; Berking C; Heppt MV
Curr Oncol; 2022 Apr; 29(5):2909-2919. PubMed ID: 35621627
[TBL] [Abstract] [Full Text] [Related]
17. Low-Dose MST-16/VP-16 Combination Chemotherapy in 9 Patients with Tumor Stage Mycosis Fungoides.
Kato Y; Fukuhara Y; Nagatani T; Kanzaki A; Mae KI; Irisawa R; Harada K; Umebayashi Y; Tsuboi R
Dermatology; 2022; 238(5):961-966. PubMed ID: 35551376
[TBL] [Abstract] [Full Text] [Related]
18. Clinical presentation, outcome, and prognostic markers in patients with intravascular large B-cell lymphoma, a lymphoma study association (LYSA) retrospective study.
Bonnet A; Bossard C; Gabellier L; Rohmer J; Laghmari O; Parrens M; Sarkozy C; Dulery R; Roland V; Llamas-Gutierrez F; Oberic L; Fornecker LM; Bounaix L; Villemagne B; Szablewski V; Choquet S; Bouabdallah K; Traverse-Glehen A; Mohty M; Sanhes L; Houot R; Gastinne T; Leux C; Le Gouill S
Cancer Med; 2022 Oct; 11(19):3602-3611. PubMed ID: 35538643
[TBL] [Abstract] [Full Text] [Related]
19. Contribution of endoplasmic reticulum stress, MAPK and PI3K/Akt pathways to the apoptotic death induced by a penicillin derivative in melanoma cells.
Bellizzi Y; Anselmi Relats JM; Cornier PG; Delpiccolo CML; Mata EG; Cayrol F; Cremaschi GA; Blank VC; Roguin LP
Apoptosis; 2022 Feb; 27(1-2):34-48. PubMed ID: 34773171
[TBL] [Abstract] [Full Text] [Related]
20. Primary cutaneous anaplastic large-cell lymphoma with DUSP22-IRF4 rearrangement following insect bites.
Zhang Y; Chen M; Yu Y; Liu X; Liu W; Jiang L; Zhang W
J Cutan Pathol; 2022 Feb; 49(2):187-190. PubMed ID: 34622970
[TBL] [Abstract] [Full Text] [Related]
[Next]
